Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
The Patient - Patient-Centered Outcomes Research
Published in: The Patient - Patient-Centered Outcomes Research 3/2016

01-06-2016 | Original Research Article

Patient Involvement in the Design of a Patient-Centered Clinical Trial to Promote Adherence to Supplemental Oxygen Therapy in COPD

Authors: Kristen E. Holm, Richard Casaburi, Scott Cerreta, Hélène A. Gussin, Julian Husbands, Janos Porszasz, Valentin Prieto-Centurion, Robert A. Sandhaus, Jamie L. Sullivan, Linda J. Walsh, Jerry A. Krishnan

Published in: The Patient - Patient-Centered Outcomes Research | Issue 3/2016

Login to get access

Abstract

Background

Patients are increasingly viewed as key stakeholders who can contribute in meaningful ways to clinical research and are emphasized in research funded by the Patient-Centered Outcomes Research Institute (PCORI). We are not aware of other peer-reviewed publications that report methods and outcomes of patient engagement to refine study design for a PCORI-sponsored clinical effectiveness trial.

Objective

The aim of this report was to describe the process and outcomes of involving patients in the design of a clinical trial to promote adherence to supplemental oxygen therapy among patients with chronic obstructive pulmonary disease.

Methods

In-person focus groups and individual discussions via telephone and email were used to elicit feedback to refine the intervention and clarify outcomes of highest importance to patients.

Results

A total of 25 patients and five caregivers provided feedback. Their feedback has informed decisions regarding the length of intervention sessions (20 min and in some cases longer was acceptable), the importance of including caregivers, and discussion topics (e.g., social discomfort about using oxygen in public, identifying personally relevant reasons to use oxygen, pulmonary rehabilitation). Multiple outcomes were rated as highly important to patients (physical function, fatigue, sleep, anxiety, depression, and ability to participate in social roles and activities), and the outcome that was ranked as most important varied by individual. Therefore, multiple patient-reported outcomes will be used as endpoints for the clinical trial.

Conclusions

Patient involvement led to refinements of the intervention and clinical trial endpoints to better address the expressed needs and concerns of patients and caregivers.
Literature
1.
Hanley B, Truesdale A, King A, Elbourne D, Chalmers I. Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey. BMJ. 2001;322(7285):519–23.CrossRefPubMedPubMedCentral
2.
Wyatt K, Carter M, Mahtani V, Barnard A, Hawton A, Britten N. The impact of consumer involvement in research: an evaluation of consumer involvement in the London Primary Care Studies Programme. Fam Pract. 2008;25(3):154–61.CrossRefPubMed
3.
Cashman SB, Adeky S, Allen AJ 3rd, Corburn J, Israel BA, Montano J, et al. The power and the promise: working with communities to analyze data, interpret findings, and get to outcomes. Am J Public Health. 2008;98(8):1407–17.CrossRefPubMedPubMedCentral
4.
Hewlett S, Wit M, Richards P, Quest E, Hughes R, Heiberg T, et al. Patients and professionals as research partners: challenges, practicalities, and benefits. Arthritis Rheum. 2006;55(4):676–80.CrossRefPubMed
5.
Shah SG, Robinson I. Benefits of and barriers to involving users in medical device technology development and evaluation. Int J Technol Assess Health Care. 2007;23(1):131–7.PubMed
6.
Decker M, Hemmerling A, Lankoande F. Women front and center: the opportunities of involving women in participatory health research worldwide. J Womens Health (Larchmt). 2010;19(11):2109–14.CrossRef
7.
Brett J, Staniszewska S, Mockford C, Herron-Marx S, Hughes J, Tysall C, et al. A systematic review of the impact of patient and public involvement on service users, researchers and communities. Patient. 2014;7(4):387–95.CrossRefPubMed
8.
Brett J, Staniszewska S, Mockford C, Herron-Marx S, Hughes J, Tysall C, et al. Mapping the impact of patient and public involvement on health and social care research: a systematic review. Health Expect. 2014;17(5):637–50.CrossRefPubMed
9.
Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med. 1980;93(3):391–8.CrossRef
10.
Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet. 1981;1(8222):681–6.
11.
Block AJ, Castle JR, Keitt AS. Chronic oxygen therapy. Treatment of chronic obstructive pulmonary disease at sea level. Chest. 1974;65(3):279–88.CrossRefPubMed
12.
13.
Crockett AJ, Cranston JM, Moss JR, Alpers JH. Effects of long-term oxygen therapy on quality of life and survival in chronic airflow limitation. Monaldi Arch Chest Dis. 1999;54(2):193–6.PubMed
14.
Eaton T, Lewis C, Young P, Kennedy Y, Garrett JE, Kolbe J. Long-term oxygen therapy improves health-related quality of life. Respir Med. 2004;98(4):285–93.CrossRefPubMed
15.
Crockett AJ, Moss JR, Cranston JM, Alpers JH. The effects of home oxygen therapy on hospital admission rates in chronic obstructive airways disease. Monaldi Arch Chest Dis. 1993;48(5):445–6.PubMed
16.
Ringbaek TJ, Viskum K, Lange P. Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease? Eur Respir J. 2002;20(1):38–42.CrossRefPubMed
17.
Stewart BN, Hood CI, Block AJ. Long-term results of continuous oxygen therapy at sea level. Chest. 1975;68(4):486–92.CrossRefPubMed
18.
Pepin JL, Barjhoux CE, Deschaux C, Brambilla C. Long-term oxygen therapy at home. Compliance with medical prescription and effective use of therapy. ANTADIR Working Group on Oxygen Therapy. Association Nationale de Traitement a Domicile des Insuffisants Respiratories. Chest. 1996;109(5):1144–50.CrossRefPubMed
19.
Katsenos S, Froudarakis ME, Charisis A, Vassiliou MP, Constantopoulos SH. Long-term oxygen therapy in Ioannina. Respiration. 2004;71(6):619–24.CrossRefPubMed
20.
Katsenos S, Charisis A, Daskalopoulos G, Constantopoulos SH, Vassiliou MP. Long-term oxygen therapy in chronic obstructive pulmonary disease: the use of concentrators and liquid oxygen systems in north-western Greece. Respiration. 2006;73(6):777–82.CrossRefPubMed
21.
22.
Donovan JL, Brindle L, Mills N. Capturing users’ experiences of participating in cancer trials. Eur J Cancer Care. 2002;11(3):210–4.CrossRef
23.
24.
Groene O. Patient and public involvement in developing patient-reported outcome measures: indispensable, desirable, challenging. Patient. 2012;5(2):75–7.CrossRefPubMed
25.
Staniszewska S, Haywood KL, Brett J, Tutton L. Patient and public involvement in patient-reported outcome measures: evolution not revolution. Patient. 2012;5(2):79–87.CrossRefPubMed
26.
Levinson W, Kao A, Kuby A, Thisted RA. Not all patients want to participate in decision making. A national study of public preferences. J Gen Intern Med. 2005;20(6):531–5.CrossRefPubMedPubMedCentral
27.
28.
Casaburi R, Porszasz J, Hecht A, Tiep B, Albert RK, Anthonisen NR, et al. Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy. COPD. 2012;9(1):3–11.CrossRefPubMed
29.
Metadata
Title
Patient Involvement in the Design of a Patient-Centered Clinical Trial to Promote Adherence to Supplemental Oxygen Therapy in COPD
Authors
Kristen E. Holm
Richard Casaburi
Scott Cerreta
Hélène A. Gussin
Julian Husbands
Janos Porszasz
Valentin Prieto-Centurion
Robert A. Sandhaus
Jamie L. Sullivan
Linda J. Walsh
Jerry A. Krishnan
Publication date
01-06-2016
Publisher
Springer International Publishing
Published in
The Patient - Patient-Centered Outcomes Research / Issue 3/2016
Print ISSN: 1178-1653
Electronic ISSN: 1178-1661
DOI
https://doi.org/10.1007/s40271-015-0150-z

Other articles of this Issue 3/2016

The Patient - Patient-Centered Outcomes Research 3/2016 Go to the issue

Leading Article

Meeting the Challenges of Intervention Research in Health Science: An Argument for a Multimethod Research Approach

Original Research Article

A Qualitative Study of Vulnerable Patient Views of Type 2 Diabetes Consumer Reports

Original Research Article

Variation in Treatment Priorities for Chronic Hepatitis C: A Latent Class Analysis

Original Research Article

Feasibility of Using Qualitative Interviews to Explore Patients’ Treatment Goals: Experience from Dermatology

Original Research Article

Validation of the Chinese Version of the Quality of Recovery-15 Score and Its Comparison with the Post-Operative Quality Recovery Scale

Original Research Article

Completing a Questionnaire at Home Prior to Needs Assessment in General Practice: A Qualitative Study of Cancer Patients’ Experience
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits